Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kristensen

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Journal of Crohn'S & Colitis|November 11, 2024
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)Kristina A Holten, Tomm Bernklev, Randi Opheim, et al.
Lancet (London, England)|April 3, 1998
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive DysfunctionJ T Moller, P Cluitmans, L S Rasmussen, et al.
BMC Microbiology|April 27, 2026
Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patientsJonas Christoffer Lindstrøm, Hilde S Vollan Gjerdrum, Ola B Brynildsrud, et al.
Microbiome Research Reports|April 22, 2026
Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categoriesSimen Hyll Hansen, Niharika Bhattacharjee, Chang Hu, et al.
Digestive Diseases and Sciences|January 12, 2026
Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III studyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.
Inflammatory Bowel Diseases|April 12, 2026
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III studyMaria G Maseng, Simen H Hansen, Olle Grännö, et al.
Inflammatory Bowel Diseases|March 10, 2025
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort)Bjorn Christian Olsen, Randi Opheim, Vendel A Kristensen, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 16, 2026
A novel diagnostic serum protein signature for pediatric inflammatory bowel diseaseCharlotte Bache-Wiig Mathisen, Niklas Nyström, Igor Bazov, et al.
Genome Medicine|January 9, 2026
Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stagesAya K H Mahdy, Hesham ElAbd, Érika Endo Kokubun, et al.
Journal of Crohn'S & Colitis|June 6, 2023
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III StudyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Journal of Crohn'S & Colitis|November 11, 2024
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)Kristina A Holten, Tomm Bernklev, Randi Opheim, et al.
Lancet (London, England)|April 3, 1998
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive DysfunctionJ T Moller, P Cluitmans, L S Rasmussen, et al.
BMC Microbiology|April 27, 2026
Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patientsJonas Christoffer Lindstrøm, Hilde S Vollan Gjerdrum, Ola B Brynildsrud, et al.
Microbiome Research Reports|April 22, 2026
Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categoriesSimen Hyll Hansen, Niharika Bhattacharjee, Chang Hu, et al.
Digestive Diseases and Sciences|January 12, 2026
Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III studyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.
Inflammatory Bowel Diseases|April 12, 2026
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III studyMaria G Maseng, Simen H Hansen, Olle Grännö, et al.
Inflammatory Bowel Diseases|March 10, 2025
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort)Bjorn Christian Olsen, Randi Opheim, Vendel A Kristensen, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 16, 2026
A novel diagnostic serum protein signature for pediatric inflammatory bowel diseaseCharlotte Bache-Wiig Mathisen, Niklas Nyström, Igor Bazov, et al.
Genome Medicine|January 9, 2026
Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stagesAya K H Mahdy, Hesham ElAbd, Érika Endo Kokubun, et al.
Journal of Crohn'S & Colitis|June 6, 2023
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III StudyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.
Pageof 15